Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Patients' refusal of surgery strongly impairs breast cancer survival.

Verkooijen HM, Fioretta GM, Rapiti E, Bonnefoi H, Vlastos G, Kurtz J, Schaefer P, Sappino AP, Schubert H, Bouchardy C.

Ann Surg. 2005 Aug;242(2):276-80.

2.

Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma.

Wang J, Wang FW.

Int J Surg Oncol. 2010;2010:381795. doi: 10.1155/2010/381795. Epub 2010 Dec 20.

3.

Characteristics of the Delayed or Refusal Therapy in Breast Cancer Patients: A Longitudinal Population-Based Study in Taiwan.

Chen SJ, Kung PT, Huang KH, Wang YH, Tsai WC.

PLoS One. 2015 Jun 26;10(6):e0131305. doi: 10.1371/journal.pone.0131305. eCollection 2015.

4.

Undertreatment strongly decreases prognosis of breast cancer in elderly women.

Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schäfer P, Kurtz J, Sappino AP, Vlastos G.

J Clin Oncol. 2003 Oct 1;21(19):3580-7. Epub 2003 Aug 11.

PMID:
12913099
5.

Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer.

Weinmann S, Taplin SH, Gilbert J, Beverly RK, Geiger AM, Yood MU, Mouchawar J, Manos MM, Zapka JG, Westbrook E, Barlow WE.

J Natl Cancer Inst Monogr. 2005;(35):33-8.

PMID:
16287883
6.

Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women.

Kaplan HG, Malmgren JA, Atwood MK.

J Geriatr Oncol. 2013 Apr;4(2):148-56. doi: 10.1016/j.jgo.2012.12.007. Epub 2013 Jan 23.

PMID:
24071540
7.

Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008.

Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF.

Ann Surg Oncol. 2015 Nov;22(12):3836-45. doi: 10.1245/s10434-015-4441-3. Epub 2015 Mar 6.

8.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

9.

Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.

Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA.

J Am Coll Surg. 2009 Mar;208(3):341-7. doi: 10.1016/j.jamcollsurg.2008.12.001. Epub 2009 Jan 21.

10.

Is surgical management compromised in elderly patients with breast cancer?

Wanebo HJ, Cole B, Chung M, Vezeridis M, Schepps B, Fulton J, Bland K.

Ann Surg. 1997 May;225(5):579-86; discussion 586-9.

11.

Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.

Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP.

J Clin Oncol. 2010 Apr 20;28(12):2038-45. doi: 10.1200/JCO.2009.25.9796. Epub 2010 Mar 22.

12.

Mortality impact of less-than-standard therapy in older breast cancer patients.

Yood MU, Owusu C, Buist DS, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA.

J Am Coll Surg. 2008 Jan;206(1):66-75. Epub 2007 Oct 3.

PMID:
18155570
13.

Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.

Christiansen P, Bjerre K, Ejlertsen B, Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen B, Toftdahl DB, Møller S, Mouridsen HT; Danish Breast Cancer Cooperative Group.

J Natl Cancer Inst. 2011 Sep 21;103(18):1363-72. doi: 10.1093/jnci/djr299. Epub 2011 Aug 31.

PMID:
21881042
14.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
15.

Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.

Hofvind S, Holen Å, Aas T, Roman M, Sebuødegård S, Akslen LA.

Eur J Surg Oncol. 2015 Oct;41(10):1417-22. doi: 10.1016/j.ejso.2015.07.002. Epub 2015 Jul 17.

PMID:
26253193
16.

Outcome analysis of breast cancer patients who declined evidence-based treatment.

Joseph K, Vrouwe S, Kamruzzaman A, Balbaid A, Fenton D, Berendt R, Yu E, Tai P.

World J Surg Oncol. 2012 Jun 26;10:118. doi: 10.1186/1477-7819-10-118.

17.

Who should not undergo breast conservation?

Nijenhuis MV, Rutgers EJ.

Breast. 2013 Aug;22 Suppl 2:S110-4. doi: 10.1016/j.breast.2013.07.021. Review.

PMID:
24074770
18.

Survival of young and older breast cancer patients in Geneva from 1990 to 2001.

Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schäfer P, Sappino AP, Kurtz J, Neyroud-Caspar I, Bouchardy C.

Eur J Cancer. 2005 Jul;41(10):1446-52.

PMID:
15919199
19.

A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women.

Inari H, Shimizu S, Suganuma N, Yoshida T, Nakayama H, Yamanaka T, Yamanaka A, Rino Y, Masuda M.

Breast Cancer. 2017 Jan;24(1):98-103. doi: 10.1007/s12282-016-0678-3. Epub 2016 Feb 11.

PMID:
26868519
20.

Stage 0 to stage III breast cancer in young women.

Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST.

J Am Coll Surg. 2000 May;190(5):523-9.

PMID:
10801018

Supplemental Content

Support Center